PLP1 and myeloid sarcoma: It has been observed that patients suffering from MS have an increased population of T-cells specific for PLP peptides and increased levels of anti- PLP181–230 specific antibodies were found in serum levels compared to healthy individuals and patients with other neurological diseases [4].